Ascend Laboratories, LLC
Ascend Laboratories, LLC has 51 FDA recalls, 5 inspections, 0 510(k) clearances and 2 compliance actions on record.
- Latest recall
- D-0045-2027 · Class II · Oct 6, 2026
- Latest inspection
- Nov 10, 2021 · VAI
Reviewing Ascend Laboratories, LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Ascend Laboratories, LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 51 | Nov 2, 2026 | File dated Oct 27, 2026 | Current |
| 510(k) clearances | 0 | Nov 2, 2026 | File dated Oct 30, 2026 | Current |
| Inspections | 5 | Nov 7, 2026 | Newest record Oct 28, 2026 | Current |
| Compliance actions | 2 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0045-2027 | Class II | Amlodipine and Olmesartan Medoxomil Tablets, 10mg/40mg, 30 Tablets, Rx only, Manufactured by: Alkem… | Oct 6, 2026 |
| D-0737-2026 | Class III | Dabigatran Etexilate Capsules, 150 mg, 60-count (6x10) blister pack further packaged in a carton, Rx… | Jul 16, 2026 |
| D-0738-2026 | Class III | Dabigatran Etexilate Capsules, 75 mg, 60-count (6x10)blister pack further packaged in a carton, Rx… | Jul 16, 2026 |
| D-0739-2026 | Class III | Dabigatran Etexilate Capsules, 75 mg, 30-count (3x10) blister pack further packaged in a carton, Rx… | Jul 16, 2026 |
| D-0712-2026 | Class II | Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bottle, Rx Only… | Jul 8, 2026 |
| D-0736-2026 | Class III | Dabigatran etexilate Capsules, 150 mg, 20-count carton (2x10), Rx only, Manufactured by: Alkem… | Jun 30, 2026 |
| D-0735-2026 | Class III | Dabigatran etexilate Capsules, 110 mg, 60-count carton (6x10), Rx Only, Manufactured by: Alkem… | Jun 30, 2026 |
| D-0597-2026 | Class II | Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg, 30-count bottle, Rx Only… | Jun 1, 2026 |
| D-0556-2026 | Class II | Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg, Rx Only, 30-count bottle, Manufactured by… | May 5, 2026 |
| D-0547-2026 | Class II | Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only… | Apr 27, 2026 |
| D-0019-2026 | Class II | Atorvastatin Calcium Tablets USP, 20 mg, Rx Only, a). 90-count(NDC 67877-512-90), b). 500-count… | Sep 19, 2025 |
| D-0020-2026 | Class II | Atorvastatin Calcium Tablets USP, 80 mg, Rx Only, a). 90-count(NDC 67877-514-90), b). 500-count(NDC… | Sep 19, 2025 |
| D-0017-2026 | Class II | Atorvastatin Calcium Tablets USP, 10 mg, Rx Only a) 90-count bottle (NDC 67877-511-90), b)… | Sep 19, 2025 |
| D-0018-2026 | Class II | Atorvastatin Calcium Tablets USP, 40 mg, Rx Only, a). 90-count (NDC 67877-513-90), b). 500-count… | Sep 19, 2025 |
| D-0645-2025 | Class II | Aripiprazole Tablets, USP, 10 mg, 30-count bottles, Rx only, Manufactured by: Alken Laboratories… | Aug 28, 2025 |
| D-0576-2025 | Class II | Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/ 40 mg, 30-count bottle, Rx Only, Manufactured by… | Jul 21, 2025 |
| D-0533-2025 | Class II | Rizatriptan Benzoate Tablets, USP, 5 mg, 18 (3x6) Unit Dose Tablets, Rx Only, Manufactured by: Alkem… | Jul 9, 2025 |
| D-0534-2025 | Class II | Rizatriptan Benzoate Tablets, USP, 10 mg, 18 (3x6) Unit Dose Tablets, Rx Only, Manufactured by… | Jul 9, 2025 |
| D-0469-2025 | Class II | Cephalexin for Oral Suspension, USP, 125 mg per 5 mL, 200 mL (when mixed), Rx Only, Manufactured by… | May 23, 2025 |
| D-0468-2025 | Class II | Cephalexin for Oral Suspension, USP, 125 mg per 5 mL, 100 mL (when mixed), Rx Only, Manufactured by… | May 23, 2025 |
Recent FDA Inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Nov 10, 2021 | Bedminster, NJ | Drugs | Voluntary Action Indicated (VAI) | 3004459274 |
| Jun 24, 2021 | Bedminster, NJ | Drugs | Voluntary Action Indicated (VAI) | 3004459274 |
| Jul 6, 2017 | Bedminster, NJ | Drugs | No Action Indicated (NAI) | 3004459274 |
| Dec 11, 2013 | Bedminster, NJ | Drugs | Official Action Indicated (OAI) | 3004459274 |
| Feb 10, 2011 | Bedminster, NJ | Drugs | No Action Indicated (NAI) | 3004459274 |